Crinetics COO Jeff Knight resigns, enters consulting agreement at $400/hr

Crinetics Pharmaceuticals, Inc.

Jeff Knight resigned as Chief Development and Operating Officer effective April 10, 2026 (previously reported March 23, 2026).
1-year consulting agreement with $400/hour rate, max 20 hours/month, renewable for 6 months.
Unvested restricted stock units and options forfeited; vested options exercisable three months after consulting ends.
Consulting agreement includes a general release of all claims against the company.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.